ALLEGRETTO WAVE EYE-Q EXCIMER LASER
Report
- Report Number
- 3003288808-2015-05833
- Event Type
- Injury
- Date Received
- July 7, 2015
- Date of Event
- February 19, 2015
- Report Date
- July 7, 2015
- Manufacturer
- WAVELIGHT GMBH
- Product Code
- LZS
- PMA / PMN Number
- P020050
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- OTHER
Narratives
THE DEVICE HISTORY RECORDS (DHR) FOR THE DEVICE WERE REVIEWED. THE ASSOCIATED DEVICE WAS RELEASED BASED ON ACCEPTANCE CRITERIA. A REVIEW OF THE TECHNICAL SERVICE ONSITE SHOWED THAT THE LASER WAS SUCCESSFULLY VERIFIED PRIOR TO AND AFTER THE DATE OF THE TREATMENT. THE LOGFILE REVIEW FOR THE DATE OF TREATMENT SHOWS NO ABNORMALITIES THAT COULD HAVE CONTRIBUTED TO REPORTED EVENT. THE TREATMENTS WERE COMPLETED TO 100% AND ALL LASER SYSTEM FUNCTIONS WERE WITHIN SPECIFICATIONS DURING THE TREATMENT DAY. NO TECHNICAL ROOT CAUSE WAS IDENTIFIED AS THE SYSTEM WAS OPERATING WITHIN SPECIFICATIONS. THE ROOT CAUSE COULD NOT BE DETERMINED CONCLUSIVELY. (B)(4).
AN OPTOMETRIST REPORTED THAT A PATIENT PRESENTED WITH LIGHT SENSITIVITY IN BOTH EYES APPROXIMATELY THREE WEEKS POST LASIK. THE PATIENT WAS NOTED TO HAVE TRANSIENT LIGHT SENSITIVITY (TLS) AND THE PREVIOUSLY PRESCRIBED TOPICAL STEROID EYE DROPS WERE INCREASED. THE PATIENT WAS SEEN IN FOLLOW UP AND WAS NOTED TO HAVE AN INCREASE IN INTRAOCULAR PRESSURE. THE TOPICAL STEROID EYE DROP WAS DISCONTINUED. THE OPTOMETRIST RE-PRESCRIBED THE STEROID AT A LATER DATE AND AGAIN THE PATIENT HAD AN INCREASE IN INTRAOCULAR PRESSURE. THE PATIENT'S CARE HAS BEEN TRANSFERRED TO ANOTHER OPHTHALMOLOGIST. ADDITIONAL INFORMATION PROVIDED STATES THAT THE PATIENT IS DOING BETTER AND VISION IS GOOD. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IS FOR THE RIGHT EYE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 441489 | ALLEGRETTO WAVE EYE-Q EXCIMER LASER | OPHTHALMIC EXCIMER LASER SYSTEM | LZS | WAVELIGHT GMBH | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR | Required Intervention |